Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Name: Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
License: Public Domain

M.D. Anderson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced malignant solid neoplasm, clinical stage iii cutaneous melanoma ajcc v8, clinical stage iv cutaneous melanoma ajcc v8, fallopian tube carcinoma, metastatic lung non-small cell carcinoma, metastatic malignant solid neoplasm

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 279529
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.